why is bpc 157 banned by wada BPC-157 peptide prohibited under WADA regulations BPC 157 Banned: Key Facts

The injection is given into the fatty subcutaneous tissue (often in the abdomen, thigh, or upper arm)

The complete AOD 9604 side effect guide covers the minor issues that some users report, including mild injection site irritation and occasional headaches, but nothing in the clinical literature suggests serious safety concerns at standard research doses

Some injections are vitamins or nutrients, such as B12, D3, MIC/B12, glutathione, CoQ10, and NAD+

Beyond Use Date Up to 120 Days from compounding (USP ) Use within this window from the date your vial is compounded

Affect Energy Levels AOD 9604 and Tirzepatide peptides may also affect energy levels in research subjects during clinical investigations